American Heart Journal
Volume 154, Issue 3 , Pages 561-566 , September 2007

Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome

  • David E. Lanfear, MD, MS

      Affiliations

    • Henry Ford Heart and Vascular Institute and Wayne State University, Detroit, MI
    • ,
  • Philip G. Jones, MS

      Affiliations

    • Mid America Heart Institute, Kansas City, MO
    • ,
  • Sharon Marsh, PhD

      Affiliations

    • Department of Medicine, Washington University School of Medicine, St Louis, MO
    • ,
  • Sharon Cresci, MD

      Affiliations

    • Cardiovascular Diseases Division, Department of Medicine, Washington University School of Medicine, St Louis, MO
    • ,
  • John A. Spertus, MD, MPH

      Affiliations

    • Mid America Heart Institute, Kansas City, MO
    • University of Missouri-Kansas City, Kansas City, MO
    • Corresponding Author InformationReprint requests: John Spertus, MD, MPH, Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111.
    • ,
  • Howard L. McLeod, PharmD

      Affiliations

    • Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC

Received 1 December 2006 ,Accepted 29 April 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported in part by R01 HS11282-01 from the Agency for Healthcare Research and Quality, the NIH Pharmacogenetics research network (U01 GM63340), a Heart Failure Society of America Research Fellowship grant, and NIH SCCOR (P50 HL077113).

 Dr Howard L. McLeod is a member of an advisory board for the US Food and Drug Administration.

PII: S0002-8703(07)00384-5

doi: 10.1016/j.ahj.2007.04.059

American Heart Journal
Volume 154, Issue 3 , Pages 561-566 , September 2007

Article Tools

* Image Usage & Resolution